B Helbig
About
In The Last Decade
B Helbig
23 papers receiving 383 citations
Peers
Comparison fields: 5 of 90
- Epidemiology 141
- Genetics 62
- Soil Science 59
- Virology 57
- Infectious Diseases 56
Countries citing papers authored by B Helbig
This map shows the geographic impact of B Helbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Helbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Helbig more than expected).
Fields of papers citing papers by B Helbig
This network shows the impact of papers produced by B Helbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Helbig. The network helps show where B Helbig may publish in the future.
Co-authorship network of co-authors of B Helbig
This figure shows the co-authorship network connecting the top 25 collaborators of B Helbig. A scholar is included among the top collaborators of B Helbig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Helbig. B Helbig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 36 | |
| 3 | 98 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 21 | |
| 7 | 72 | |
| 8 | 28 | |
| 9 | Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. | 30 |
| 10 | Lipoxygenase-inhibitory action of antiviral polymeric oxidation products of polyphenols. | 5 |
| 11 | [Biotransformation of pyridazines. 1. Pyridazine and 3-methylpyridazine]. | 1 |
| 12 | 3 | |
| 13 | 37 | |
| 14 | [Inhibition of several strains of influenza virus type A and B by phenolic polymers]. | 4 |
| 15 | 2 | |
| 16 | [Penetration kinetics of potential virustatics into the human skin]. | 1 |
| 17 | [Antiviral effect of enzymatically and nonenzymatically oxidized caffeic and hydrocaffeic acids against Herpesvirus hominis type 1 and type 2 in vitro]. | 1 |
| 18 | [Effect of phenol ring polymers on the release of plasminogen activators]. | 1 |
| 19 | [Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author's transl)]. | 20 |
| 20 | In vitro studies of the antiviral activity of enzymatically oxidized o-diphenolic compounds against herpes simplex virus type 1 and type 2. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.